{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:38:03Z","timestamp":1778747883573,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10620-016-4400-2","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T08:58:24Z","timestamp":1481187504000},"page":"456-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Paulo Gustavo","family":"Kotze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansur Paulo","family":"Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorete Maria","family":"da Silva Kotze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Olandoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Vital","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Augusto Real","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Lourdes Setsuko","family":"Ayrizono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela de Oliveira","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Saddy Rodrigues","family":"Coy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"issue":"9853","key":"4400_CR1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart DC, Sandborn WJ. Crohn\u00b4s disease. Lancet. 2012;380:1590\u20131605.","journal-title":"Lancet."},{"issue":"15","key":"4400_CR2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, Van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis-factor alfa for Crohn\u00b4s disease. N Engl J Med. 1997;337:1029\u20131035.","journal-title":"N Engl J Med"},{"key":"4400_CR3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I Study Group. Maintenance infliximab for Crohn\u00b4s disease: the ACCENT I randomised trial. Lancet. 2002;359:1541\u20131549.","journal-title":"Lancet"},{"key":"4400_CR4","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn\u00b4s Disease. N Engl J Med. 2004;350:876\u2013885.","journal-title":"N Engl J Med"},{"key":"4400_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.03134.x","volume":"25","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. Review article: altering the natural history of Crohn\u00b4s disease: evidence for and against current therapies. Aliment Pharmacol Ther. 2006;25:3\u201312.","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"4400_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","volume":"4","author":"A Dignass","year":"2010","unstructured":"Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based\u00a0Consensus\u00a0on the diagnosis and management of\u00a0Crohn\u2019s disease: current management. J Crohns Colitis. 2010;4:28\u201362.","journal-title":"J Crohns Colitis."},{"key":"4400_CR7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/00365521.2012.660540","volume":"47","author":"A El-Hussuna","year":"2012","unstructured":"El-Hussuna A, Andersen J, Bisgaard T, et al. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn\u2019s disease. Scand J Gastroenterol. 2012;47:662\u2013668.","journal-title":"Scand J Gastroenterol."},{"issue":"9","key":"4400_CR8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ijsu.2014.07.271","volume":"12","author":"I Papaconstantinou","year":"2014","unstructured":"Papaconstantinou I, Zeglinas C, Gazouli M, et al. Effect of infliximab on the healing of intestinal anastomosis. An experimental study in rats. Int J Surg. 2014;12:969\u2013975.","journal-title":"Int J Surg."},{"issue":"3","key":"4400_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/08941939.2014.995244","volume":"28","author":"K Strebel","year":"2015","unstructured":"Strebel K, Nielsen SR, Biagini M, Qvist N. Effect of\u00a0Humira\u00ae on intestinal anastomotic response in rabbits. J Invest Surg. 2015;28:167\u2013172.","journal-title":"J Invest Surg."},{"issue":"10","key":"4400_CR10","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s11605-008-0646-0","volume":"12","author":"KA Appau","year":"2008","unstructured":"Appau KA, Fazio VW, Shen B, et al. Use of infliximab within 3\u00a0months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn\u2019s patients. J Gastrointest Surg. 2008;12:1738\u20131744.","journal-title":"J Gastrointest Surg."},{"key":"4400_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ajg.2012.464","volume":"108","author":"A Syed","year":"2013","unstructured":"Syed A, Cross RK, Flasar MH. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn\u2019s disease patients. Am J Gastroenterol. 2013;108:583\u2013593.","journal-title":"Am J Gastroenterol."},{"issue":"12","key":"4400_CR12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s11605-010-1341-5","volume":"14","author":"BS Nasir","year":"2010","unstructured":"Nasir BS, Dozois EJ, Cima RR, et al. Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn\u2019s disease. J Gastrointest Surg. 2010;14:1859\u20131865.","journal-title":"J Gastrointest Surg."},{"key":"4400_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/apt.12159","volume":"37","author":"BM N\u00f8rg\u00e5rd","year":"2013","unstructured":"N\u00f8rg\u00e5rd BM, Nielsen J, Qvist N, Gradel KO, de Muckadell OB, Kjeldsen J. Pre-operative use of anti-TNF-\u03b1 agents and the risk of post-operative complications in patients with Crohn\u2019s disease\u2014a nationwide cohort study. Aliment Pharmacol Ther. 2013;37:214\u2013224.","journal-title":"Aliment Pharmacol Ther."},{"key":"4400_CR14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gutjnl-2011-301495","volume":"62","author":"M Waterman","year":"2013","unstructured":"Waterman M, Xu W, Dinani A, et al. Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut. 2013;62:387\u2013394.","journal-title":"Gut."},{"issue":"5","key":"4400_CR15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.9439","volume":"101","author":"P Myrelid","year":"2014","unstructured":"Myrelid P, Marti-Gallostra M, Ashraf S, et al. Complications in surgery for Crohn\u2019s disease after preoperative antitumour necrosis factor therapy. Br J Surg. 2014;101:539\u2013545.","journal-title":"Br J Surg."},{"issue":"12","key":"4400_CR16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/DCR.0b013e3182a48505","volume":"56","author":"A El-Hussuna","year":"2013","unstructured":"El-Hussuna A, Krag A, Olaison G, Bendtsen F, Gluud LL. The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn\u2019s disease: a systematic review. Dis Colon Rectum. 2013;56:1423\u20131433.","journal-title":"Dis Colon Rectum."},{"key":"4400_CR17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.crohns.2013.01.014","volume":"7","author":"V Billioud","year":"2013","unstructured":"Billioud V, Ford AC, Tedesco ED, Colombel JF, Roblin X, Peyrin-Biroulet L. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. J Crohns Colitis. 2013;7:853\u2013867.","journal-title":"J Crohns Colitis."},{"issue":"3","key":"4400_CR18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijsu.2013.12.015","volume":"12","author":"ZP Yang","year":"2014","unstructured":"Yang ZP, Hong L, Wu Q, Wu KC, Fan DM. Preoperative infliximab use and postoperative complications in Crohn\u2019s disease: a systematic review and meta-analysis. Int J Surg. 2014;12:224\u2013230.","journal-title":"Int J Surg."},{"key":"4400_CR19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/apt.12313","volume":"37","author":"N Narula","year":"2013","unstructured":"Narula N, Charleton D, Marshall JK. Meta-analysis: peri-operative anti-TNF\u03b1 treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:1057\u20131064.","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"4400_CR20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/SLA.0000000000000757","volume":"261","author":"C Lau","year":"2015","unstructured":"Lau C, Dubinsky M, Melmed G, et al. The impact of preoperative serum anti-TNF\u03b1 therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg. 2015;261:487\u2013496.","journal-title":"Ann Surg."},{"key":"4400_CR21","unstructured":"Brouquet A, Maggiori L, Zerbib P et al. Anti-TNF therapy is associated with increased risk of postoperative morbidity after surgery for ileocolonic Crohn disease: outcome analysis in a prospective nationwide cohort of 592 patients conducted by the GETAID chirurgie group. Oral presentation 027, ECCO congress, 2016, Amsterdam [abstract]."},{"key":"4400_CR22","unstructured":"PUCCINI trial. http:\/\/ccfacra.org\/?page_id=85 . Accessed 02 2016."},{"key":"4400_CR23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00268-009-9957-x","volume":"33","author":"AA Indar","year":"2009","unstructured":"Indar AA, Young-Fadok TM, Heppell J, Efron JE. Effect of perioperative immunosuppressive medication on early outcome in Crohn\u2019s disease patients. World J Surg. 2009;33:1049\u20131052.","journal-title":"World J Surg."},{"issue":"1","key":"4400_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ajg.2013.374","volume":"109","author":"PG Kotze","year":"2014","unstructured":"Kotze PG, Coy CSR. The impact of preoperative anti-TNF in surgical and infectious complications of abdominal procedures for Crohn\u2019s disease:\u00a0controversy\u00a0still persists. Am J Gastroenterol. 2014;109:139.","journal-title":"Am J Gastroenterol."},{"key":"4400_CR25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0016-5085(03)00883-7","volume":"125","author":"FN Aberra","year":"2003","unstructured":"Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003;125:320\u2013326.","journal-title":"Gastroenterology"},{"key":"4400_CR26","doi-asserted-by":"crossref","unstructured":"Lightner AL, Raffals LE, Mathis KL, Cima RR, Tse CS, Pemberton JH, Dozois EJ, Loftus EV. Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease. J Crohns Colitis. 2016. [Epub ahead of print].","DOI":"10.1093\/ecco-jcc\/jjw147"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4400-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-016-4400-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-016-4400-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T02:15:40Z","timestamp":1718936140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-016-4400-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4400"],"URL":"https:\/\/doi.org\/10.1007\/s10620-016-4400-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}